Announcements

At their meeting held today, the Audit Committee reviewed the valuation reports of Nueclear Healthcare Ltd., (NHL) received from Karvy Investor Services Ltd. and noted the long gestation period of this business in terms of returns. The Committee also felt that accepting the offer of Dr. A. Velumani, Chairman, MD & CEO, to acquire the entire shareholding in NHL may result in dilution of his focus and time, which is not in the interest of the Company. Hence, the Audit Committee recommended that it is not expedient to accept the offer of Dr. A. Velumani at this juncture.

The Board, which met subsequently, accepted the above recommendation of the Audit Committee.

None of the promoter-directors, were present during the discussions at the Audit Committee Meeting and at the meeting of the Board of Directors.

Intimation about Board Meeting scheduled to be held on Saturday, September 21, 2019 to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company’s shareholding in NHL or dispose it of.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Sunidhi Securities & Finance Limited, at 4.00 P.M. on Thursday, September 19, 2019.

(ii) Meeting with the representative(s) of India Ratings & Research (Fitch Group), at 4.00 P.M. on Friday, September 20, 2019.

Intimation that  the representative(s) of Angle Broking Limited would be having a Con-call with us by 11.00 A.M. on Monday, September 16, 2019.

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.30 A.M. on Tuesday, August 27, 2019 at the Corporate Office of the Company.

Intimation that Mr. Anand Velumani, Director, Nueclear Healthcare Limited, our wholly owned subsidiary, would be participating at the ‘15^th Annual Global Investor Conference’ organized by M/s. Motilal Oswal Financial Services Limited, at Hotel Grand Hyatt, Mumbai on 20^th August, 2019, where representatives of various fund houses would be meeting him.

Intimation about conference call for Indian and Overseas Investors to be held on 14-08-2019 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2019

Click here to see the invite

Intimation about the outcome of the Board Meeting held on 10-08-2019

(i) Approval of Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2019.

(ii) Approval of issue and allotment of new equity shares not exceeding 37,859 shares to those employees who may be exercising the Stock Options granted to them in 2016 and vesting on them on 12^th September 2019, subject to compliance with applicable regulations.

Intimation about Board Meeting scheduled to be held on Saturday, August 10, 2019 to inter alia, consider and approve the Unaudited financial results (both Stand-alone and Consolidated) for the quarter ended June 30, 2019.

Intimation about (i) 19th Annual General Meeting convened to be held on 24-08-2019 at 3.00 P.M. at Hotel Yogi Midtown, Turbhe , Navi Mumbai,

(ii) Book-Closure from 18-08-2019 to 24-08-2019 (both days inclusive) for payment of final dividend of Rs.20/- (on approval by shareholders), &

(iii) E-voting facility available to the Shareholders.

Intimation about meeting of representative(s) of Baring Private Equity Asia, with us at 3.30 P.M. on Friday, July 05, 2019, at the Corporate Office of the Company, followed by a visit to our Lab.

Intimation that Trading Window shall remain closed for Directors, Designated Employees and Connected Persons with immediate effect and will be reopened after 48 hours of date of announcement / declaration of Unaudited Financial Results for the Quarter ended June 30, 2019.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of PhillipCapital India Private Limited, at 3.30 P.M. on Wednesday, July 03, 2019.

(ii) Meeting with the representative(s) of Centrum Capital Ltd., at 4.30 P.M. on Friday, July 05, 2019.

Post-script of the conference call of Indian and Overseas Investors held on 21-05-2019 to discuss about audited financial results (stand-alone & consolidated) for the year ended 31-03-2019. Click here

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Securities Investment Management Pvt. Ltd., at 3.30 P.M. on Wednesday, June 26, 2019.

(ii) Meeting with the representative(s) of HDFC Securities Limited, at 4.30 P.M. on Wednesday, June 26, 2019.

Intimation that while considering the offer made by Dr. A. Velumani, Chairman, MD & CEO to acquire the Company’s shareholding in NHL, both the Audit Committee and the Board of Directors have unanimously decided that the Company has to determine whether it would be beneficial for the Company to hive off the subsidiary or retain it, and for this purpose, it would be advisable to obtain one more valuation report to ensure that the valuation of the subsidiary has been correctly ascertained. The Committee decided to appoint a SEBI approved merchant banker to submit a valuation report, within the shortest possible time, and then take a decision.  None of the Promoter-directors were present during the discussions.

Intimation about the following forthcoming meetings:

(i) Meeting with the representative(s) of Sundaram Mutual Fund, at 10.30 A.M. on Saturday, June 15, 2019.

(ii) Meeting with the representative(s) of Reliance Mutual Fund, at 12.00 Noon on Saturday, June 15, 2019.

(iii) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 10.00 A.M. on Wednesday, June 19, 2019.

(iv) Meeting with the representative(s) of Grandeur Peak Global Advisors, at 02.00 P.M. on Thursday, June 27, 2019.

Intimation that a meeting of the Board of Directors will be held on Thursday, June 13, 2019, to discuss about the offer made by Dr. A. Velumani, Chairman, Managing Director & CEO to acquire the shareholding of the Company in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary of the Company.

Intimation about the following forthcoming meetings:

i) Meeting with the representative(s) of CWC Advisors, at 02.00 P.M. on Tuesday, May 28, 2019 at the Corporate Office of the Company.

ii) Meeting with the representative(s) of Mirabilis Investment Trust, at 04.00 P.M. on Wednesday, May 29, 2019 at the Corporate Office of the Company.

iii) Participation of our representative(s) at “Trinity India- 2019” Organized by Batlivala & Karani Securities India Pvt. Ltd. at Hotel Trident, BKC on Friday, May 31, 2019 from 10.00 A.M., where representatives of various fund houses would be met.

Intimation that  the representative(s) of SAIF Partners would be having a Con-call with us by 3.00 P.M. on Thursday, May 23, 2019.

Intimation about meeting of representative(s) of Anived Portfolio Managers Private Limited, with us at 02.00 P.M. on Wednesday, May 22, 2019 at the Corporate Office of the Company.

Intimation that we had participated in the tender floated by Municipal Corporation of Greater Mumbai (the “MCGM”) for outsourcing of laboratory investigative services “Aapli Chikitsa”, and we have  now received a  letter from MCGM informing us that our tender has been accepted by them; we have been  authorized to provide laboratory investigative services “Aapli Chikitsa” over  a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in Western Suburban Zone and City Zone  of Mumbai. The total contract cost of the tender to be executed over the period of 4 years is Rs. 532.27 million, with an assurance of about 60% of total samples test per year; we have since complied with the terms and conditions and are poised to commence the operation on tender awarded by Municipal Corporation of Greater Mumbai for availing laboratory investigative services “Aapli Chikitsa” within next 30 days.

Intimation that at the Board Meeting held on 18-05-2019, when the Auditors pointed out the impairment of investment in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary, Dr. A. Velumani, Chairman, Managing Director & CEO has offered to buy the entire shareholding of the Company in NHL at the current investment value of Rs. 194.67 crores to ensure that there is no loss to the public shareholders; however, all required formalities will be complied with by the Company for such a transaction; we were waiting for the concurrence from the Auditors to intimate this and hence the delay.

Intimation about conference call for Indian and Overseas Investors to be held on 21-05-2019 to discuss about Audited financial results (Stand-alone and Consolidated) for the quarter / full year ended 31-03-2019

Click here to see the invite

Intimation of decisions taken at the Board Meeting held on May 18, 2019, about approval of the Audited Financial Statements (both Stand-alone and Consolidated) for the quarter and the whole year ended 31-03-2019, Recommendation of a Dividend of Rs.20/- per share for 2018-19 and granting of Stock Options for employees for 2018-19.

Intimation about Board Meeting scheduled to be held on Saturday, May 18, 2019 to inter alia, consider and approve the audited financial results (both Stand-alone and Consolidated) for the year ended  31st March 2019, to consider declaration of dividend, if any, and to consider issue of stock options to employees for 2018-19.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from April 26, 2019 (as already announced) up to end of the day on May 21, 2019.

Intimation about meeting of representative(s) of SAIF Partners, with us at 10.00 A.M. on Thursday, May 02, 2019 at the Corporate Office of the Company, followed by a visit to our Lab.

Intimation that Trading Window shall remain closed for Directors, Employees and Connected Persons from April 26, 2019 until 48 hours after announcement of the financial results for FY 2018-19. The actual date of re-opening of trading window will be notified in due course.

Confirmation of compliance of provisions of Reg. 74(5) of SEBI (Depositories & Participants) Regulations 2018, as certified by the Company’s RTA

Intimation about non-applicability of framework for Fund Raising by issue of Debt Securities by Large Entities notified by SEBI